Spots Global Cancer Trial Database for voriconazole
Every month we try and update this database with for voriconazole cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies | NCT04551963 | B-cell Malignan... | Zanubrutinib Fluconazole Diltiazem Voriconazole Clarithromycin | 18 Years - | BeiGene | |
| Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients | NCT03067350 | Invasive Asperg... Haematological ... Voriconazole | 18 Years - | University Hospital, Grenoble | ||
| Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy | NCT04743544 | Adverse Drug Re... | Voriconazole | 2 Years - 18 Years | Dokuz Eylul University | |
| Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy | NCT02381080 | B-Cell Chronic ... | Ibrutinib Erythromycin Voriconazole | 18 Years - | Janssen Research & Development, LLC | |
| Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections | NCT00059878 | Infection Unspecified Adu... | recombinant int... voriconazole | 2 Years - | National Cancer Institute (NCI) | |
| Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis | NCT00904995 | Leukemia Fungal Infectio... | Voriconazole Voriconazole | 18 Years - | M.D. Anderson Cancer Center | |
| Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant | NCT01503515 | Fungal Infectio... Hematopoietic a... | Caspofungin Ace... Fluconazole Laboratory Biom... Voriconazole | 3 Months - 20 Years | Children's Oncology Group | |
| Blood and Marrow Transplant Clinical Research Network | NCT00023530 | Bone Marrow Tra... Blood Disease Hematopoietic S... Leukemia Multiple Myelom... Myelodysplastic... Graft vs Host D... | fluconazole voriconazole bone marrow tra... thalidomide dexamethasone | 2 Years - | National Heart, Lung, and Blood Institute (NHLBI) | |
| Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems | NCT00238355 | Infection Unspecified Adu... | caspofungin ace... voriconazole | 18 Years - | OHSU Knight Cancer Institute | |
| Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis | NCT00904995 | Leukemia Fungal Infectio... | Voriconazole Voriconazole | 18 Years - | M.D. Anderson Cancer Center | |
| Blood and Marrow Transplant Clinical Research Network | NCT00023530 | Bone Marrow Tra... Blood Disease Hematopoietic S... Leukemia Multiple Myelom... Myelodysplastic... Graft vs Host D... | fluconazole voriconazole bone marrow tra... thalidomide dexamethasone | 2 Years - | National Heart, Lung, and Blood Institute (NHLBI) | |
| Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy | NCT04743544 | Adverse Drug Re... | Voriconazole | 2 Years - 18 Years | Dokuz Eylul University | |
| Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections | NCT00418951 | Acute Myelogeno... Myelodysplastic... | Voriconazole Liposomal ampho... Liposomal ampho... | 18 Years - | M.D. Anderson Cancer Center | |
| DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia | NCT04752163 | Hematopoietic a... Recurrent Acute... Recurrent Acute... Recurrent Chron... Recurrent Myelo... Refractory Acut... Refractory Acut... Refractory Chro... Refractory Myel... | DS-1594b Azacitidine Cyclophosphamid... Cytarabine Dexamethasone Filgrastim Leucovorin Mesna Methotrexate Posaconazole Prednisone Rituximab Venetoclax Vincristine Voriconazole | 18 Years - | M.D. Anderson Cancer Center | |
| Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies | NCT04551963 | B-cell Malignan... | Zanubrutinib Fluconazole Diltiazem Voriconazole Clarithromycin | 18 Years - | BeiGene | |
| A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing | NCT01416025 | Fungal Infectio... | Prospective TDM... | 12 Years - 100 Years | Johns Hopkins University | |
| Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients | NCT03067350 | Invasive Asperg... Haematological ... Voriconazole | 18 Years - | University Hospital, Grenoble | ||
| Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems | NCT00238355 | Infection Unspecified Adu... | caspofungin ace... voriconazole | 18 Years - | OHSU Knight Cancer Institute | |
| Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia | NCT00152594 | Leukemia, Myelo... | voriconazole | 18 Years - | University of Cologne | |
| Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy | NCT01148160 | Invasive Fungal... | voriconazole | 15 Years - | Asan Medical Center | |
| Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia | NCT00152594 | Leukemia, Myelo... | voriconazole | 18 Years - | University of Cologne | |
| Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy | NCT02381080 | B-Cell Chronic ... | Ibrutinib Erythromycin Voriconazole | 18 Years - | Janssen Research & Development, LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
